ArticleFrontiers in pharmacology2023

Comparative pharmacoeconomic analysis of rituximab and traditional tacrolimus regimens in membranous nephropathy in China.

Li Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.